中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 36 Issue 11
Nov.  2020
Turn off MathJax
Article Contents

Risk factors,diagnosis,and updated classification of hepatorenal syndrome

DOI: 10.3969/j.issn.1001-5256.2020.11.003
  • Received Date: 2020-07-31
  • Published Date: 2020-11-20
  • Hepatorenal syndrome( HRS) is a common complication of decompensated cirrhosis and is traditionally defined as progressive oliguria or anuria,azotemia,dilutional hyponatremia,and hyponatremia,while renal insufficiency without marked organic lesions in the kidney is the typical manifestation of HRS. Recent studies have found that besides the abnormalities in hemodynamics,inflammatory response,oxidative stress,and direct renal tubular toxicity of bile salts are jointly involved in the development and progression of HRS. HRS is not the only renal complication in patients with liver cirrhosis,and it is only a functional form of acute kidney injury( AKI). HRS meeting the criteria for AKI is called HRS-AKI,which is formerly known as HRS-Ⅰ type. For cirrhotic patients with acute kidney disease or chronic kidney disease,if they meet the criteria for HRS,they can be diagnosed with HRS-NAKI,which is formerly known as HRS-Ⅱ type. The most common risk factors for HRS are infection,digestive bleeding,and large-volume paracentesis without transfusion of human serum albumin for volume expansion.

     

  • loading
  • [1] LI C,LI WG,XU XY. Clinical advances in hepatorenal syndrome in liver cirrhosis[J]. J Clin Intern Med,2019,36(12):799-802.(in Chinese)李晨,李文刚,徐小元.肝硬化肝肾综合征的临床进展[J].临床内科病杂志,2019,36(12):799-802.
    [2] GINES A,ESCORSELL A,GINES P,et al. Incidence,predictive factors,and prognosis of the hepatorenal syndrome in cirrhosis with ascites[J]. Gastroenterology,1993,105(1):229-236.
    [3] WAGN YJ,PING XG. Clinical effect of ascites ultrafiltration and reinfusion in treatment of patients with decompensated cirrhosis,intractable liver ascites,and typeⅡhepatorenal syndrome[J]. Chin J Ctrl Endem Dis,2017,32(10):249-253.(in Chinese)王艳景,平骁功.腹水超滤浓缩回输治疗肝硬化失代偿期合并顽固性肝腹水伴Ⅱ型肝肾综合征的临床效果[J].中国地方病防治杂志,2017,32(10):249-253.
    [4] GINES P,SOLAE,ANGELI P,et al. Hepatorenal syndrome[J]. Nat Rev Dis Primers,2018,4(1):23.
    [5] de MATTOSAZ,de MATTOS AA,MENDEZ-SANCHEZ N.Hepatorenal syndrome:Current concepts related to diagnosis and management[J]. Ann Hepatol,2016,15(4):474-481.
    [6] PERICLEOUSM,SARNOWSKIA,MOREA,et al. The clinical management of abdominal ascites,spontaneous bacterial peritonitis and hepatorenalsyndrome:A review of curent guidelines and recommendations[J]. Eur J Gastroenterol Hepatol,2016,28(3):e108.
    [7] European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis[J]. J Hepatol,2010,53(3):397-417.
    [8] WIEST R,KRAG A,GERBES A. Spontaneous bacterial peritonitis:Recent guidelines and beyond[J]. Gut,2012,61(2):297-310.
    [9] EGEROD ISRAELSEN M,GLUUD LL,KRAG A. Acute kidney injury and hepatorenal syndrome in cirrhosis[J]. J Gastroenterol Hepato,2015,30(2):236-243.
    [10] LI SY,TIAN YJ,LI DC,et al. Risk factors for hepatorenal syndrome in patients with decompensated cirrhosis[J]. J Chin Physician,2016,18(11):1723-1725.(in Chinese)李思阳,田英俊,李德春,等.肝硬化患者失代偿期发生肝肾综合征的危险因素分析[J].中国医师杂志,2016,18(11):1723-1725.
    [11] ZHU XZ,ZHAI YF,WANG JJ. Study on the risk factors of the occurrence of hepato renal syndrome for patients with acute on chronic hepatitis B liver failure[J]. J Chin Physician,2014,16(9):1196-1199.(in Chinese)朱喜增,翟玉峰,王江华.慢加急性乙型肝炎肝衰竭患者发生肝肾综合征的影响因素研究[J].中国医师杂志,2014,16(9):1196-1199.
    [12] YE YN,ZHANG ZJ,HE G,et al. Analysis of high-risk factors for hepatorenal syndrome in patients with hepatitis B-related acute-on-chronic liver failure[J]. Hainan Med J,2019,30(24):3145-3148.(in Chinese)叶一农,张志侨,何纲,等.乙型肝炎相关慢加急性肝衰竭患者发生肝肾综合征的高危因素分析[J].海南医学,2019,30(24):3145-3148.
    [13] ARROYO V,GINES P,GERBES AL,et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club[J]. Hepatology,1996,23(1):164-176.
    [14] SALERNO F,GERBES A,GINES P,et al. Diagnosis,prevention and treatment of hepatorenal syndrome in cirrhosis[J].Gut,2007,56(9):1310-1318.
    [15] ANGELI P,GINES P,WONG F,et al. Diagnosis and management of acute kidney injury in patients with cirrhosis:Revised consensus recommendations of the International Club of Ascites[J]. J Hepatol,2015,62(4):968-974.
    [16] Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol,2017,33(10):1847-1863.(in Chinese)中华医学会肝病分会.肝硬化腹水及相关并发症的诊疗指南[J].临床肝胆病杂志,2017,33(10):1874-1863.
    [17] BELCHER JM,EDELSTEIN CL,PARIKH CR. Clinical applications of biomarkers for acute kidney injury[J]. Am J Kidney Dis,2011,57(6):930-940.
    [18] BELCHER JM,SANYAL AJ,PEIXOTO AJ,et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury[J]. Hepatology,2014,60(2):622-632.
    [19] HUELIN P,SOLAE,ELIA C,et al. Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis:A prospective study[J]. Hepatology,2019,70(1):319-333.
    [20] AMIN AA,ALABSAWY EI,JALAN R,et al. Epidemiology,pathophysiology,and management of hepatorenal syndrome[J]. Semin Nephrol,2019,39(1):17-30.
    [21] European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol,2018,69(2):406-460.
    [22] CHAWLA LS,BELLOMO R,BIHORAC A,et al. Acute kidney disease and renal recovery:Consensus report of the Acute Disease Quality Initiative(ADQI)16 Workgroup[J]. Nat Rev Nephrol,2017,13(4):241-257.
    [23] HUAN HD,CHENG CW. Latest advances in the definition,typing,and pathophysiology of hepatorenal syndrome[J].Chin Hepatol,2020,25(1):7-9.(in Chinese)宦红娣,陈成伟.肝肾综合征定义、分型及病理生理新进展[J].肝脏,2020,25(1):7-9.
    [24] ANGELI P,GARCIA-TSAO G,NADIM MK,et al. News in pathophysiology,definition and classification of hepatorenal syndrome:A step beyond the International Club of Ascites(ICA)consensus document[J]. J Hepatol,2019,71(4):811-822.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (5600) PDF downloads(263) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return